Consensus Alkermes plc

Equities

ALKS

IE00B56GVS15

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
27.07 USD -0.66% Intraday chart for Alkermes plc +0.37% -2.42%

Evolution of the average Target Price on Alkermes plc

Price target over the last 5 years

History of analyst recommendation changes

74f85c7e0821b277c54c7.lNXO_jgojr8bQ3H-4UwnDHS0fmEWsfQxHAq7wdVi84w.wL2Ai3xR_cVVGxe8qCZLRTXrIUxZx7pgf2KOgJxWt7Xa5YrGSm3_9F0MQQ~b7f5e40d4749d8e5de930781db6cb708
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing MT
Baird Initiates Alkermes With Outperform Rating, Price Target is $37 MT
UBS Downgrades Alkermes to Sell From Neutral, Price Target is $25 MT
Piper Sandler Raises Price Target on Alkermes to $39 From $32.54, Maintains Overweight Rating MT
Piper Sandler Adjusts Price Target on Alkermes to $35 From $37, Maintains Overweight Rating MT
Evercore ISI Upgrades Alkermes to Outperform From In-Line MT
UBS Initiates Coverage on Alkermes With Neutral Rating, $31 Price Target MT
Piper Sandler Adjusts Price Target on Alkermes to $37 From $35, Maintains Overweight Rating MT
Mizuho Adjusts Alkermes Price Target to $40 From $36, Maintains Buy Rating MT
Stifel Nicolaus Adjusts Alkermes Price Target to $33 From $31, Maintains Hold Rating MT
HC Wainwright Adjusts Alkermes' Price Target to $34 From $32, Keeps Neutral Rating MT
Mizuho Securities Adjusts Alkermes Price Target to $36 From $37, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Alkermes to $31 From $29, Maintains Neutral Rating MT
Mizuho Adjusts Alkermes' Price Target to $37 From $36, Keeps Buy Rating MT
JPMorgan Adjusts Alkermes Price Target to $29 From $33, Maintains Neutral Rating MT
Mizuho Adjusts Price Target on Alkermes to $36 From $34, Maintains Buy Rating MT
Piper Sandler Upgrades Alkermes to Overweight From Neutral, Adjusts Price Target to $30 From $26 MT
BofA Securities Upgrades Alkermes to Neutral From Underperform, Adjusts Price Target to $25 From $27 MT
Piper Sandler Starts Alkermes at Neutral With $26 Price Target MT
Mizuho Securities Adjusts Price Target on Alkermes to $34 From $36, Maintains Buy Rating MT
SVB Leerink Raises Alkermes Price Target to $27 From $24, Maintains Market Perform Rating MT
HC Wainwright Adjusts Alkermes' Price Target to $32 from $30, Keeps Neutral Rating MT
SVB Leerink Adjusts Alkermes Price Target to $25 From $24, Maintains Market Perform Rating MT
Goldman Sachs Starts Alkermes at Buy With $35 Price Target MT
Citigroup Adjusts Alkermes' Price Target to $26 From $22, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
27.07 USD
Average target price
34.83 USD
Spread / Average Target
+28.68%
High Price Target
43 USD
Spread / Highest target
+58.85%
Low Price Target
25 USD
Spread / Lowest Target
-7.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alkermes plc

Baird
UBS
Piper Sandler
Evercore ISI
Mizuho Securities
Stifel Nicolaus
HC Wainwright
JPMorgan Chase
BofA Securities
SVB Leerink
Goldman Sachs
Citigroup
Cantor Fitzgerald
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings